Product Information
DRIZALMA SPRINKLE DR 30 MG CAP is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $7.2517 per EA under NDC 47335061730. Its NADAC has been published 88 times since Dec 18, 2024.
FDA first approved this application on Jul 19, 2019.
The High Outlier badge above means this manufacturer's average price in the Duloxetine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335061730
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA212516FDA Approved
7/19/2019
On Market Since
6/10/2024
Pharmacological Classes
Price Statistics
The NADAC for DRIZALMA SPRINKLE DR 30 MG CAP has been published 88 times since Dec 18, 2024, and over the history we have for it it has risen 12.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.2517 per EA |
|---|---|
| All-time high | $7.2517 (Aug 19, 2026) |
| All-time low | $6.4287 (Mar 19, 2025) |
| 52-week high | $7.2517 |
| 52-week low | $7.1056 |
| Median price | $7.1216 |
| Average price | $7.0104 |
| Largest weekly change | +9.9% (Apr 9, 2025) |
| Weeks tracked | 88 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DRIZALMA SPRINKLE DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DRIZALMA SPRINKLE DR 30 MG CAP, manufactured by Sun Pharmaceutical Industries Inc., is $7.2517 per EA (NDC 47335061730), effective Aug 19, 2026.
How has the price of DRIZALMA SPRINKLE DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DRIZALMA SPRINKLE DR 30 MG CAP has risen 12.4%. It has been tracked across 88 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for DRIZALMA SPRINKLE DR 30 MG CAP?
Since Dec 18, 2024, the NADAC for DRIZALMA SPRINKLE DR 30 MG CAP has ranged from a low of $6.4287 (Mar 19, 2025) to a high of $7.2517 (Aug 19, 2026), with a median of $7.1216 per EA.
Are there cheaper alternatives to DRIZALMA SPRINKLE DR 30 MG CAP?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 30 MG CAP, is $0.0782 per EA — about 99% below DRIZALMA SPRINKLE DR 30 MG CAP.
Who manufactures DRIZALMA SPRINKLE DR 30 MG CAP?
DRIZALMA SPRINKLE DR 30 MG CAP (NDC 47335061730) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.